ArticleAllergy2022

Reply to: "Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients".

Yael Renert-Yuval et al.PubMed ↗Publisher ↗

No numbers read from the abstract.